Metronomic Therapy in Patients With Metastatic Melanoma

NCT01542255 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Low accrual not allowing to support statistical endpoints

Conditions

Metastatic Melanoma

Interventions

DRUG: vinblastine
DRUG: Cyclophosphamide
DRUG: dacarbazine

Sponsor

Dartmouth-Hitchcock Medical Center